In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation

Nature Medicine

Volumn 6, Issue 12, 2000, Pages 1362-1367

  Bucci, Mariarosaria ^a,b   Gratton, Jean Philippe ^a   Rudic, Radu Daniel ^a   Acevedo, Lisette ^a   Roviezzo, Fiorentina ^b   Cirino, Giuseppe ^b   Sessa, William C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dipartimento di Farmacologia Sperimental   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CAVEOLIN; CHIMERIC PROTEIN; DEXAMETHASONE; GLUCOCORTICOID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; INFLAMMATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAPILLARY PERMEABILITY; CAVEOLIN 1; CAVEOLINS; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; VASODILATOR AGENTS;

EID: 0034529950     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/82176     Document Type: Article

References (29)

1. Caveolins, liquid-ordered domains, and signal transduction
2. Membrane microdomains and caveolae
3. Src tyrosine kinases, G alpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases
4. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A
5. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells
6. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo
7. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains
8. Caveolin, cholesterol and Ras signalling
9. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
10. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
11. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling
12. Impaired wound healing and angiogenesis in eNOS-deficient mice
13. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling
14. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: A green fluorescent protein study
15. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity
16. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase
17. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis
18. Trojan peptides: The penetratin system for intracellular delivery
19. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
20. The third helix of the Antennapedia homeodomain translocates through biological membranes
21. Molecular biology of prostanoid biosynthetic enzymes and receptors
22. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies
23. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane
24. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation
25. Modulation of acute inflammation by endogenous nitric oxide
26. Effect of nitric oxide synthase inhibitors on basal microvessel permeability and endothelial cell [Ca2+]i
27. Inhibition of nitric oxide synthase as a potential therapeutic target
28. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
29. Dynamic activation of endothelial nitric oxide synthase by Hsp90